by John Walker, MS, LAT, ATC, CES Of all the health trends to emerge in the 21st century, few (if any) have achieved the notoriety and effectiveness of GLP-1 receptor agonists, most commonly known today as Ozempic. From speculative tabloid headlines to nationwide ad campaigns, Ozempic has taken the world